Intravenous vs Oral Iron Does Not Increase CKD Risk : vimars

Intravenous vs oral iron therapy do not increase the risk for chronic kidney disease among patients with normal kidney function.

Related Keywords

Florida , United States , Orlando , American , Csabap Kovesdy , , Va Memphis Medical Center , University Of Tennessee Health Science Center , American Society Of Nephrology Kidney Week , American Society , Kidney Week , Medical Center , Tennessee Health Science Center ,